Conformational analysis of human calcitonin in solution

Journal of Peptide Science

Volumn 12, Issue 1, 2006, Pages 51-57

  Ogawa, Kiyoshi ^a   Nishimura, Shigenori ^b   Doi, Masamitsu ^a   Takashima, Hiroyuki ^a   Nishi, Yoshinori ^a,c   Yoshida, Takuya ^a   Ohkubo, Tadayasu ^a   Kobayashi, Yuji ^a,c  

^a OSAKA UNIVERSITY   (Japan)

^b Osaka Prefecture University   (Japan)

^c OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Amphiphilic helix; Calcitonin; Eel calcitonin; Human calcitonin; NMR

Indexed keywords

AROMATIC AMINO ACID; CALCITONIN; CALCITONIN DERIVATIVE; ELCATONIN; SALCATONIN; TRIFLUOROETHANOL; WATER;

ALPHA HELIX; ARTICLE; BIOLOGICAL ACTIVITY; CONFORMATIONAL TRANSITION; HORMONE ACTION; HORMONE DETERMINATION; HUMAN; HYDROGEN BOND; HYDROPHOBICITY; HYPOCALCEMIA; MATHEMATICAL COMPUTING; NONHUMAN; NUCLEAR OVERHAUSER EFFECT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION; ULTIMOBRANCHIAL BODY;

ANIMALS; CALCITONIN; EELS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; REFERENCE STANDARDS; SALMON; SOLUTIONS;

EID: 29844456257     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/psc.687     Document Type: Article

References (40)

1. Azria M. The Calcitonin; Physiology and Pharmacology. Karger: Basel, 1989.
2. Guttman S. Chemistry and structure-activity relationship of natural and synthetic calcitonins. In Calcitonin 1980: Chemistry, Physiology, Pharmacology, and Clinical Aspects, Pecile A (ed.). Exerpta Medica: Princeton: NJ, 1980; 11-24.
3. Merle M, Lefevre G, Milhaud G. Predicted secondary structure of calcitonin in relation to the biological activity. Biochem. Biophys. Res. Commun. 1979; 87: 455-460.
4. Epand RM, Epand RF, Orlowski RC, Schulueter RJ, Boni LT, Hui SW. Amphipathic helix and its relationship to the interaction of calcitonin with phospholipids. Biochemistry 1983; 22: 5074-5084.
5. Moe GR, Miller RJ, Kaiser ET. Design of a peptide hormone: Synthesis and characterization of a model peptide with calcitonin-like activity. J. Am. Chem. Soc. 1983; 105: 4100-4102.
6. Meyer JP, Pelton JT, Hoflack J, Saudek V. Solution structure of salmon calcitonin. Biopolymers 1991; 31: 233-241.
7. Meadows RP, Nikonowicz EP, Jones CR, Bastian JW, Gorenstein DG. Two-dimensional NMR and structure determination of salmon calcitonin in methanol. Biochemistry 1991; 30: 1247-1254.
8. 1H NMR assignment and secondary structure determination of salmon calcitonin in solution. Biochemistry 1989; 28: 7996-8002.
9. 1H NMR study of human calcitonin in solution. Biochemistry 1991; 30: 2364-2371.
10. Motta A, Pastore A, Goud NA, Morelli MAC. Solution conformation of salmon calcitonin in sodium dodecyl sulfate micelles as determined by two-dimensional NMR and distance geometry calculations. Biochemistry 1991; 30: 10 444-10 450.
11. Motta A, Andreotti G, Amodeo P, Strazzullo G, Morelli MAC. Solution structure of human calcitonin in membrane-mimetic environment: The role of the amphiphilic helix. Proteins 1998; 32: 314-323.
12. 2 salmon calcitonin: A biologically potent synthetic analog. Endocrinology 1981; 108: 831-835.
13. Findlay DM, Michelangeli VP, Martin TJ, Orlowski RC, Seyler JK. Conformational requirements for activity of salmon calcitonin. Endocrinology 1985; 117: 801-805.
14. Epand RM, Stahl G, Orlowski RC. Conformational and biological properties of partial sequences of salmon calcitonin. Int. J. Peptide Protein Res. 1986; 27: 501-507.
15. Orlowski RC, Epand RM, Stanfford AR. Biological potent analogues of salmon calcitonin which do not contain an N-terminal disulfide-bridge ring structure. Eur. J. Biochem. 1987; 162: 399-402.
16. Epand RM, Epand RF, Stafford AR, Orlowski RC. Deletion sequences of salmon calcitonin that retain the essential biological and conformational features of the intact molecule. J. Med. Chem. 1988; 31: 1595-1598.
17. 19 sCT) retains full potency without inducing anorexia in rats. Endocrinology 1990; 126: 2845-2848.
18. Epand RM, Epand RF. Conformational flexibility and biological activity of salmon calcitonin. Biochemistry 1986; 25: 1964-1968.
19. 16 human calcitonin. Endocrinology 1983; 112: 1288-1291.
20. Maier R, Kamber B, Rinker B, Pittel W. Analogues of human calcitonin. Clin. Endocrinol. 1976; 5: 327-332.
21. Ogawa K, Nishimura S, Uchiyama S, Kobayashi K, Kyogoku Y, Hayashi M, Kobayashi Y. Conformation analysis of eel calcitonin. Comparison with the conformation of elcatonin. Eur. J. Biochem. 1998; 257: 331-336.
22. Katahira R, Doi M, Kyogoku Y, Nosaka-Yamada A, Yamasaki K, Takai M, Kobayashi Y. Solution structure of a human calcitonin analog elucidated by NMR and distance geometry calculations. Int. J. Peptide Protein Res. 1995; 45: 305-311.
23. Doi M, Kobayashi Y, Kyogoku Y, Gohda K, Takimoto M. Structure study of human calcitonin. Proceeding of the 11th American Peptide Symposium, River JE, Marshall GR (eds). ESCOM; Leiden, 1989; 165-167.
24. Cohn EJ, Edsall JT. Proteins, Amino Acids and Peptides as Ions and Dipolar Ions. Reinhold: New York, 1943.
25. 1H NMR spectra of proteins via double quantum filtering. Biochem. Biophys. Res. Commun. 1983; 117: 479-485.
26. Jeener J, Meier BH, Bachmann P, Ernst RR. Investigation of exchange processes by two-dimensional NMR spectroscopy. J. Chem. Phys. 1979; 71: 4546-4553.
27. Kumar A, Ernst RR, Wüthrich K. A two-dimensional nuclear Overhauser enhancement (2D NOE), experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules. Biochem. Biophys. Res. Commun. 1980; 95: 1-6.
28. States DJ, Haberkorn RA, Ruben DJ. A two-dimensional nuclear Overhauser experiment with pure absorption phase in four quadrants. J. Magn. Reson. 1982; 48: 286-292.
29. Takashima H, Mimura N, Ohkubo T, Yoshida T, Tamaoki H, Kobayashi Y. Distributed computing and NMR constraint-based high-resolution structure determination: Applied for bioactive peptide endothelin-1 to determine C-terminal folding. J. Am. Chem. Soc. 2004; 126: 4504-4505.
30. Schwieters CD, Kuszewski JJ, Tjandra N, Clore GM. The Xplor-NIH NMR molecular structure determination package. J. Magn. Res. 2003; 160: 65-73.
31. Sonnichsen FD, Van Eyk JE, Hodges RS, Sykes BD. Effect of trifluoroethanol on protein secondary structure: An NMR and CD study using a synthetic actin peptide. Biochemistry 1992; 31: 8790-8798.
32. Siligardi G, Drake AF, Mascagni P, Neri P, Lozzi L, Niccolai N, Gibbons WA. Resolution of conformational equilibria in linear peptides by circular dichroism in cryogenic solvents. Biochem. Biophys. Res. Commun. 1987; 143: 1005-1011.
33. Blanco FJ, Jimenez MA, Pineda A, Rico N, Santori J, Nieto JL. NMR solution structure of the isolated N-terminal fragment of protein-G B1 domain. Evidence of trifluoroethanol induced native-like β-hairpin formation. Biochemistry 1994; 33: 6004-6014.
34. Viguera AR, Jimenez MA, Rico M, Serrano L. Conformational analysis of peptides corresponding to β-hairpins and a β-sheet that represent the entire sequence of the α-spectrin SH3 domain. J. Mol. Biol. 1996; 255: 507-521.
35. Ogawa K, Nishimura S, Doi M, Kyogoku Y, Hayashi M, Kobayashi Y. Conformational analysis of elcatonin in solution. Eur. J. Biochem. 1994; 222: 659-666.
36. Kanaori K, Nosaka YA. Study of human calcitonin fibrillation by proton nuclear magnetic resonance spectroscopy. Biochemistry 1995; 34: 12 138-12 143-.
37. Wüthrich K. NMR of Proteins and Nucleic Acids. John Wiley: New York, 1986.
38. Wüthrich K, Billeter M, Braun W. Pseudo-structure for the 20 common amino acids for use in studies of protein conformations by measurements of intramolecular proton-proton distance constraints with nuclear magnetic resonance. J. Mol. Biol. 1983; 169: 949-961.
39. 1H NMR assignments and their impact on the precision of protein structure determinations in solution. J. Am. Chem. Soc. 1989; 111: 3997-4004.
40. Moe GR, Kaiser ET. Design, synthesis and characterization of a model peptide having potent calcitonin-like biological activity; Implication for calcitonin structure/activity. Biochemistry 1985; 24: 1971-1976.